BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10389587)

  • 21. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics.
    Shatat L; Gloyeske N; Madan R; O'Neil M; Tawfik O; Fan F
    Hum Pathol; 2013 Dec; 44(12):2684-9. PubMed ID: 24071019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-needle aspiration cytology of lobular carcinoma in situ.
    Ustün M; Berner A; Davidson B; Risberg B
    Diagn Cytopathol; 2002 Jul; 27(1):22-6. PubMed ID: 12112810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
    Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytopathological grading, as a predictor of histopathological grade, in ductal carcinoma (NOS) of breast, on air-dried Diff-Quik smears.
    Khan MZ; Haleem A; Al Hassani H; Kfoury H
    Diagn Cytopathol; 2003 Oct; 29(4):185-93. PubMed ID: 14506669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration.
    Chhieng DC; Fernandez G; Cangiarella JF; Cohen JM; Waisman J; Harris MN; Roses DF; Shapiro RL; Symmans WF
    Cancer; 2000 Apr; 90(2):96-101. PubMed ID: 10794158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
    Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
    Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidental finding of mammary carcinoma in lumpectomy specimens.
    Tang P; Hajdu SI; Conte CC; Filardi DA
    Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
    van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ
    Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytologic diagnosis of ductal versus lobular carcinoma of the breast.
    de las Morenas A; Crespo P; Moroz K; Donnelly MM
    Acta Cytol; 1995; 39(5):865-9. PubMed ID: 7571961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
    Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
    Esposito NN; Dabbs DJ; Bhargava R
    Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lobular neoplasia on core needle biopsy does not require excision.
    Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
    Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Carcinoma in situ of the breast].
    Laenkholm AV; Hoffmann J; Rank FE
    Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast.
    Susnik B; Worth A; Palcic B; Poulin N; LeRiche J
    Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.